本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viking Therapeutics, Inc.

40.50
-0.1000-0.25%
成交量:434.24万
成交额:1.80亿
市值:45.78亿
市盈率:-19.11
高:43.15
开:42.09
低:40.01
收:40.60
52周最高:62.50
52周最低:18.92
股本:1.13亿
流通股本:1.10亿
量比:1.29
换手率:3.95%
股息:- -
股息率:- -
每股收益(TTM):-2.1195
每股收益(LYR):-1.0085
净资产收益率:-29.23%
总资产收益率:-20.48%
市净率:6.42
市盈率(LYR):-40.16

数据加载中...

2024/07/30

关联方拟减持公告

Form144 | Viking Therapeutics高管Brian Lian拟减持115,859股,总价约667万美元
2024/07/30

关联方拟减持公告

Form144 | Viking Therapeutics高管Marianna Mancini拟减持18026股,总价约102.99万美元
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/06/04

重要事件披露

Form 8-K - Current report
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities